SR

Stephan Roever

Hoffmann-La Roche: 53 patents #37 of 3,238Top 2%
VL Vernalis Research Limited: 8 patents #11 of 57Top 20%
CT C4 Therapeutics: 2 patents #25 of 35Top 75%
UP University Of Pittsburgh: 2 patents #100 of 521Top 20%
Overall (All Time): #42,387 of 4,157,543Top 2%
57
Patents All Time

Issued Patents All Time

Showing 26–50 of 57 patents

Patent #TitleCo-InventorsDate
8410107 N-pyridin-3-yl or N-pyrazin-2-yl carboxamides Uwe Grether, Paul Hebeisen, Torsten Hoffmann 2013-04-02
8288541 Piperazine amide derivatives Henrietta Dehmlow, Bernd Kuhn, Ulrike Obst Sander, Tanja Schulz-Gasch, Matthew Wright +1 more 2012-10-16
8227491 5-(3,4-dichloro-phenyl)-N-(2-hydroxy-cyclohexyl)-6-(2,2,2-trifluoro-ethoxy)-nicotinamide and salts thereof Matthew Wright 2012-07-24
8188093 Pyrazinecarboxamide derivatives as HDL-cholesterol raising agents Mirjana Andjelkovic, Agnes Benardeau, Evelyne Chaput, Paul Hebeisen, Matthias Nettekoven +2 more 2012-05-29
8088920 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as HDL-cholesterol raising agents Paul Hebeisen, Constantinos G. Panousis, Matthew Wright 2012-01-03
7897621 2-trifluoromethylnicotinamide derivatives as HDL-cholesterol raising agents Paul Hebeisen, Constantinos G. Panousis, Pius Waldmeier, Matthew Wright 2011-03-01
7812028 3-pyridinecarboxamide derivatives as HDL-cholesterol raising agents Mirjana Andjelkovic, Agnes Benardeau, Evelyne Chaput, Paul Hebeisen, Matthias Nettekoven +2 more 2010-10-12
7781593 5-phenyl-nicotinamide derivatives Paul Hebeisen 2010-08-24
7691863 Pyrazine-2-carboxamide derivatives as CB2 receptor modulators Michel Dietz, Sabine Gruener, Paul Hebeisen, Sylvie C. Meyer Reigner, Matthias Nettekoven +2 more 2010-04-06
7629346 Pyrazinecarboxamide derivatives as CB1 antagonists Paul Hebeisen, Hans Iding, Matthias Nettekoven, Ulrike Obst Sander, Urs Weiss +1 more 2009-12-08
7625902 Imidazolidinone derivatives Henrietta Dehmlow, Bernd Kuhn, Ulrike Obst Sander, Tanja Schulz-Gasch, Matthew Wright 2009-12-01
7579369 CB 1 receptor inverse agonists Alexander V. Mayweg, Hans-Peter Marty, Werner Mueller, Robert Narquizian, Werner Neidhart +1 more 2009-08-25
7572801 Pyridopyrimidinone derivatives which are HM74A agonists Aurelia Conte, Henrietta Dehmlow, Uwe Grether, Nicole A. Kratochwil, Holger Kuehne +4 more 2009-08-11
7563910 Heterocyclic cannabinoid receptor antagonists Alexander V. Mayweg, Robert Narquizian, Philippe Pflieger 2009-07-21
7547699 Tetracyclic 6 azapyrazinoindolines as 5HT2C receptor agonists for obesity Paul Hebeisen, Nathaniel Julius Thomas Monck, Hans Richter 2009-06-16
7384945 Indole or benzimidazole derivatives as CB1 inverse agonists Konrad Bleicher, Matthias Nettekoven, Philippe Pflieger 2008-06-10
7371751 Thiazole derivatives Matthias Nettekoven 2008-05-13
7323466 Morpholine derivatives as 5HT2C receptor agonists for the treatment of obesity Jonathan Mark Bentley, Claire Elizabeth Dawson, Wolfgang Guba, Paul Hebeisen, Nathaniel Julius Thomas Monck +3 more 2008-01-29
7297707 Benzothiazolyl derivatives Matthias Nettekoven 2007-11-20
7294644 CB 1 receptor inverse agonists Alexander V. Mayweg, Hans-Peter Marty, Werner Mueller, Robert Narquizian, Werner Neidhart +1 more 2007-11-13
7253281 Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles Jonathan Mark Bentley, Paul Hebeisen, Patrizio Mattei, Marc Muller, Hans Richter +1 more 2007-08-07
7229999 Pyridine-3-carboxamide derivatives as CB1 inverse agonists Paul Hebeisen, Hans Iding, Matthias Nettekoven, Ulrike Obst, Beat Wirz 2007-06-12
7208494 5HT2c receptor agonists Toby Jonathan Blench, Paul Hebeisen, Hans Richter 2007-04-24
7098337 1,2,3,4,9,9a-hexahydro-2,4a,5-triaza-fluorene and 1,2,3,4-tetrahydro-2,4a,5-triaza-fluorene derivatives David Reginald Adams, Jonathan Mark Bentley, Toby Jonathan Blench, Paul Hebeisen, Nathaniel Julius Thomas Monck +3 more 2006-08-29
7022707 Piperazine derivatives David Reginald Adams, Jonathan Mark Bentley, James Edward Paul Davidson, Claire Elizabeth Dawson, Ashley Roger George +9 more 2006-04-04